The Global Veterinary Reference Laboratory Market was valued at USD 4.9 billion in 2024 and is estimated to grow at a CAGR of 10.6% to reach USD 13.3 billion by 2034. A major driver of this growth is the rising incidence of chronic and zoonotic diseases in farm and companion animals. This increase in disease burden has sparked greater demand for diagnostic services, especially as awareness among pet owners regarding early diagnosis of conditions like diabetes, cancer, and parasitic infections continues to grow. In the livestock industry, stricter requirements around food safety and animal health are further encouraging the adoption of advanced testing services.
Public and private investments, driven by regulatory efforts centered on improving animal health management, are fueling the development of diagnostic infrastructure. Expanding networks of veterinary diagnostic laboratories and growing collaborations between clinics and reference facilities are helping to extend services into previously underserved markets. Additionally, a rise in pet insurance coverage is making veterinary diagnostics more financially accessible to pet owners, enhancing the utilization of reference laboratory services and accelerating the market’s momentum across both developed and emerging economies.
In 2024, the clinical chemistry segment achieved a valuation of USD 1.8 billion due to the critical role these tests play in analyzing blood and bodily fluids. These tests are essential for assessing internal organ functions, electrolyte levels, and overall metabolic status. They are particularly relevant for detecting chronic diseases such as renal disorders, diabetes, and endocrine conditions in pets and livestock. The growing use of automated, high-throughput analyzers in reference labs has helped deliver quick and accurate results, meeting the increasing demand for both routine and emergency diagnostic services.
The clinical pathology segment captured a 34.6% share in 2024 and remains a cornerstone of veterinary diagnostics. This category includes vital services like hematology, cytology, urinalysis, and chemistry-based tests that help identify various disease conditions in animals. Clinical pathology serves as the first line of evaluation in veterinary healthcare, aiding in everything from routine health monitoring to diagnosing complex illnesses. With chronic and infectious diseases becoming more common, there is heightened reliance on these tests for managing animal health across both clinical and preventive care settings.
U.S. Veterinary Reference Laboratory Market reached USD 1.7 billion in 2024. Its growth is driven by high pet ownership rates, increasing veterinary expenditures, and strong access to modern animal care services. The country's well-established veterinary infrastructure, along with the widespread adoption of pet insurance, is encouraging more frequent diagnostic testing. This environment supports the expansion of advanced reference laboratory services in the country and contributes significantly to the overall market.
Key players operating in the Global Veterinary Reference Laboratory Market include Zoetis, Heska Corporation, IDEXX Laboratories, Thermo Fisher Scientific, Antech Diagnostics (Mars), Virbac, Nova Biomedical, Vaxxinova, Boehringer Ingelheim International, Laboklin, GD Animal Health, Neogen Corporation, and Colorado State University. To strengthen their position in the veterinary reference laboratory market, companies are implementing a range of strategic initiatives.
These include expanding their laboratory networks and entering strategic partnerships with veterinary clinics to boost service accessibility. Many firms are also investing in next-generation diagnostic tools and automation to deliver faster, more accurate results. Emerging markets through acquisitions and localized service offerings, allowing them to reach more customers while enhancing operational scalability.
This product will be delivered within 2-4 business days.
Public and private investments, driven by regulatory efforts centered on improving animal health management, are fueling the development of diagnostic infrastructure. Expanding networks of veterinary diagnostic laboratories and growing collaborations between clinics and reference facilities are helping to extend services into previously underserved markets. Additionally, a rise in pet insurance coverage is making veterinary diagnostics more financially accessible to pet owners, enhancing the utilization of reference laboratory services and accelerating the market’s momentum across both developed and emerging economies.
In 2024, the clinical chemistry segment achieved a valuation of USD 1.8 billion due to the critical role these tests play in analyzing blood and bodily fluids. These tests are essential for assessing internal organ functions, electrolyte levels, and overall metabolic status. They are particularly relevant for detecting chronic diseases such as renal disorders, diabetes, and endocrine conditions in pets and livestock. The growing use of automated, high-throughput analyzers in reference labs has helped deliver quick and accurate results, meeting the increasing demand for both routine and emergency diagnostic services.
The clinical pathology segment captured a 34.6% share in 2024 and remains a cornerstone of veterinary diagnostics. This category includes vital services like hematology, cytology, urinalysis, and chemistry-based tests that help identify various disease conditions in animals. Clinical pathology serves as the first line of evaluation in veterinary healthcare, aiding in everything from routine health monitoring to diagnosing complex illnesses. With chronic and infectious diseases becoming more common, there is heightened reliance on these tests for managing animal health across both clinical and preventive care settings.
U.S. Veterinary Reference Laboratory Market reached USD 1.7 billion in 2024. Its growth is driven by high pet ownership rates, increasing veterinary expenditures, and strong access to modern animal care services. The country's well-established veterinary infrastructure, along with the widespread adoption of pet insurance, is encouraging more frequent diagnostic testing. This environment supports the expansion of advanced reference laboratory services in the country and contributes significantly to the overall market.
Key players operating in the Global Veterinary Reference Laboratory Market include Zoetis, Heska Corporation, IDEXX Laboratories, Thermo Fisher Scientific, Antech Diagnostics (Mars), Virbac, Nova Biomedical, Vaxxinova, Boehringer Ingelheim International, Laboklin, GD Animal Health, Neogen Corporation, and Colorado State University. To strengthen their position in the veterinary reference laboratory market, companies are implementing a range of strategic initiatives.
These include expanding their laboratory networks and entering strategic partnerships with veterinary clinics to boost service accessibility. Many firms are also investing in next-generation diagnostic tools and automation to deliver faster, more accurate results. Emerging markets through acquisitions and localized service offerings, allowing them to reach more customers while enhancing operational scalability.
Comprehensive Market Analysis and Forecast
- Industry trends, key growth drivers, challenges, future opportunities, and regulatory landscape
- Competitive landscape with Porter’s Five Forces and PESTEL analysis
- Market size, segmentation, and regional forecasts
- In-depth company profiles, business strategies, financial insights, and SWOT analysis
This product will be delivered within 2-4 business days.
Table of Contents
Chapter 1 Methodology and Scope
Chapter 2 Executive Summary
Chapter 3 Industry Insights
Chapter 4 Competitive Landscape, 2024
Chapter 5 Market Estimates and Forecast, By Technology, 2021 - 2034 ($ Mn)
Chapter 6 Market Estimates and Forecast, By Application, 2021 - 2034 ($ Mn)
Chapter 7 Market Estimates and Forecast, By Animal Type, 2021 - 2034 ($ Mn)
Chapter 8 Market Estimates and Forecast, By Region, 2021 - 2034 ($ Mn)
Chapter 9 Company Profiles
COMPANIES MENTIONED
The companies featured in this veterinary reference laboratory market report include:- Antech Diagnostics
- Boehringer Ingelheim International
- Colorado State University
- GD Animal Health
- Heska Corporation
- IDEXX Laboratories
- Laboklin
- Neogen Corporation
- Nova Biomedical
- Thermo Fisher Scientific
- Virbac
- VCA
- Vaxxinova
- Zoetis
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 136 |
| Published | June 2025 |
| Forecast Period | 2024 - 2034 |
| Estimated Market Value ( USD | $ 4.9 Billion |
| Forecasted Market Value ( USD | $ 13.3 Billion |
| Compound Annual Growth Rate | 10.6% |
| Regions Covered | Global |
| No. of Companies Mentioned | 15 |
